BLUEBERRY PRESERVE F4 -Blueberry Preserve F3 x Blueberry Preserve F3 (all proceeds donated to Seeds the Feed)

BLUEBERRY PRESERVE F4 -Blueberry Preserve F3 x Blueberry Preserve F3 (all proceeds donated to Seeds the Feed)


Blueberry Preserve f4

Blueberry Preserve f3 x Blueberry Preserve f3

Blueberry Preserve’s line was created utilizing a 1990’s vintage Blueberry, outcrossed to another DJ Short creation, First Light. The progeny were then bred in every filial generation— f1 x f1; f2 x f2; f3 x f3 —with each successive generation being selected for traits reminiscent of a beloved blueberry selection we used to cherish decades ago. As a result, the Blueberry Preserve f3 mother used in the creation of the f4 release is as true to the vintage Blueberry as we could get. With blue-tinted flower and hints of purple, she shines through with a pure blueberry expression; no candy, muffin, or pancakes. 

Medium yield; ~8-9 week flowering time; medium height

Regular seeds, 12+ seeds per pack

42 in stock


Blueberry Preserve Release 

Seeds that Feed is a seed company born out of the idea that the cannabis industry is a reflection of the plant we love; a medicine that imparts humility, promotes empathetic understanding, and inspires us to evolve and heal. As a cannabis community we are capable of creating fantastic change, and Seeds that Feed aims to help leverage our collective efforts toward positive impacts by providing top quality genetics grown with intention, with 100% of its proceeds going to charity. 

The Blueberry Preserve Collection utilizes re-worked vintage Blueberry genetics from the 1990’s and combines them with both heirloom classics and some of the best modern cultivars, resulting in some truly unique and beautiful pairings. As the initial release from Seeds that Feed, the proceeds from Blueberry Preserve will go toward local food assistance, providing meals to those in trying times by purchasing wholesale-bought food stuffs which are delivered to food banks, soup kitchens, and community centers.

Future projects are already in the works including more exciting in-house generic releases as well as industry-bridging collaborations aimed at bringing further relief to those who need it most.